Managing adult patients with infectious diseases in emergency departments: international ID-IRI study
dc.contributor.author | Erdem, Hakan | |
dc.contributor.author | Hargreaves, Sally | |
dc.contributor.author | Ankarali, Handan | |
dc.contributor.author | Caskurlu, Hulya | |
dc.contributor.author | Ceviker, Sevil Alkan | |
dc.contributor.author | Bahar-Kacmaz, Asiye | |
dc.contributor.author | Alsalman, Jameela | |
dc.date.accessioned | 2021-05-03T20:28:03Z | |
dc.date.available | 2021-05-03T20:28:03Z | |
dc.date.issued | 2020 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | We aimed to explore factors for optimizing antimicrobial treatment in emergency departments. A single-day point prevalence survey was conducted on January 18, 2020, in 53 referral/tertiary hospitals in 22 countries. 1957 (17%) of 11557 patients presenting to EDs had infections. The mean qSOFA score was 0.37 +/- 0.74. Sepsis (qSOFA >= 2) was recorded in 218 (11.1%) patients. The mean qSOFA score was significantly higher in low-middle (1.48 +/- 0.963) compared to upper-middle (0.17 +/- 0.482) and high-income (0.36 +/- 0.714) countries ( P < 0.001). Eight (3.7%) patients with sepsis were treated as outpatients. The most common diagnoses were upper-respiratory (n = 877, 43.3%), lower-respiratory (n = 316, 16.1%), and lower-urinary (n = 201, 10.3%) infections. 1085 (55.4%) patients received antibiotics. The most-commonly used antibiotics were beta-lactam (BL) and BL inhibitors (n = 307, 15.7%), third-generation cephalosporins (n = 251, 12.8%), and quinolones (n = 204, 10.5%). Irrational antibiotic use and inappropriate hospitalization decisions seemed possible. Patients were more septic in countries with limited resources. Hence, a better organizational scheme is required. | en_US |
dc.identifier.doi | 10.1080/1120009X.2020.1863696 | en_US |
dc.identifier.issn | 1120-009X | |
dc.identifier.issn | 1973-9478 | |
dc.identifier.pmid | 33734040 | en_US |
dc.identifier.scopus | 2-s2.0-85102939065 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.uri | https://doi.org/10.1080/1120009X.2020.1863696 | |
dc.identifier.uri | https://hdl.handle.net/11454/69729 | |
dc.identifier.wos | WOS:000630391700001 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Journal of Chemotherapy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Emergency | en_US |
dc.subject | infection | en_US |
dc.subject | sepsis | en_US |
dc.subject | treatment | en_US |
dc.subject | antibiotic | en_US |
dc.subject | elderly | en_US |
dc.title | Managing adult patients with infectious diseases in emergency departments: international ID-IRI study | en_US |
dc.type | Article | en_US |